Aquestive Therapeutics Inc
Ownership
Ownership Structure
Who owns Aquestive Therapeutics Inc (AQST)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 90.1% of the shares are freely tradable; institutional investors hold 60.6%.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Bratton Capital Management, L.P. | 7.82 | 9,810,958 | +0.0 | 06/30/2026 |
| BlackRock Inc | 6.43 | 8,069,373 | +7.5 | 06/30/2026 |
| RTW INVESTMENTS, LLC | 5.92 | 7,426,471 | +0.0 | 06/30/2026 |
| Vanguard Capital Management, LLC | 3.65 | 4,584,533 | +3.2 | 06/30/2026 |
| Federated Hermes Inc | 2.48 | 3,112,561 | +5.9 | 06/30/2026 |
| State Street Corp | 2.33 | 2,928,020 | +15.0 | 06/30/2026 |
| Geode Capital Management, LLC | 2.09 | 2,622,888 | +8.9 | 06/30/2026 |
| Samsara BioCapital, LLC | 1.99 | 2,500,000 | +0.0 | 06/30/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Vanguard MStar Total Stk Mkt Idx Invest | 2.71 | 3,403,709 | +0.0 | 09/30/2026 |
| iShares Russell 2000 ETF | 2.26 | 2,832,827 | -1.1 | 09/30/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Insider holdings
| Person | Role | Shares | Value | As of | Type |
|---|---|---|---|---|---|
| Barber Daniel | President and CEO | 627,317 | 2,383,805 $ | Oct 15, 2026 | direct |
| Boyd Peter E. | Chief People Officer | 284,024 | 1,079,291 $ | Sep 9, 2026 | direct |
| Korczynski Sherry | Chief Commercial Officer | 235,689 | 895,618 $ | Sep 9, 2026 | direct |
| Jung Cassie | Chief Operating Officer | 206,833 | 785,965 $ | Sep 3, 2026 | direct |
| Cochran John | Director | 161,715 | 614,517 $ | Oct 21, 2026 | direct |
Holdings as of each person's most recent SEC Form 4 filing — excluding options and RSUs, which are not shares yet. Holdings may have changed between two filings.
Insiders
Insider Transactions
| Date | Person | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Oct 21, 2026 | Cochran John | Director | Other | 62,229 | 0.00 | – |
| Oct 15, 2026 | Barber Daniel | President and CEO | Sell | 25,000 | 4.22 | 105,600 |
| Sep 15, 2026 | Barber Daniel | President and CEO | Sell | 25,000 | 4.82 | 120,488 |
| Sep 9, 2026 | Korczynski Sherry | Chief Commercial Officer | Sell | 8,750 | 5.22 | 45,675 |
| Sep 9, 2026 | Korczynski Sherry | Chief Commercial Officer | Other | 8,750 | 2.65 | 23,188 |
| Sep 9, 2026 | Boyd Peter E. | Chief People Officer | Other | 2,293 | 0.96 | 2,201 |
| Sep 8, 2026 | Barber Daniel | President and CEO | Other | 91,743 | 0.96 | 88,073 |
| Sep 3, 2026 | Jung Cassie | Chief Operating Officer | Other | 4,587 | 0.96 | 4,404 |
| Aug 17, 2026 | Barber Daniel | President and CEO | Sell | 25,000 | 4.29 | 107,168 |
| Aug 14, 2026 | Korczynski Sherry | Chief Commercial Officer | Other | 2,714 | 4.25 | 11,535 |
| Jul 16, 2026 | Barber Daniel | President and CEO | Sell | 20,369 | 4.00 | 81,509 |
| Jul 15, 2026 | Barber Daniel | President and CEO | Sell | 4,631 | 4.03 | 18,683 |
Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character. View all insider transactions →
Data as of: November 4, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.